The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Incidence of febrile neutropenia with adjuvant docetaxel and cyclophosphamide in patients with early breast cancer.
F. D. S. Marinho
No relevant relationships to disclose
M. d. S. d. S. Lopes
No relevant relationships to disclose
M. M. F. Monteiro
No relevant relationships to disclose
M. Gifoni
No relevant relationships to disclose